drugset / Trial / NCT04482829
TCM in the Treatment of Lung Adenocarcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate the efficacy and safety of Jin-yuan-kang granule in the treatment of lung adenocarcinoma (LUAD) preliminarily, and provide reference for further study.
Timeline
- Start
- 2020-09-15
- Primary completion
- 2020-12-30
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jing-yan-kang Granule | Unknown | — | — |
| Background | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |